$4.70 -0.02 (-0.42%)
12/3/2009 3:56 PM

SenoRx, Inc. (SENO)

CAPS Rating: 4 out of 5

The Company develops, manufactures and sells minimally-invasive medical devices for the diagnosis of breast cancer.

Recs

0
Member Avatar janvandebong (81.55) Submitted: 1/3/2008 12:35:24 PM : Outperform Start Price: $8.50 SENO Score: -23.82

I wouldn't buy it, I like p/e ratios too much - but I could see this becoming an intuitive surgical-type stock eventually. It's growing, paying off debt, & this price seems to be a reasonable jumping off point.

Report this Post 0 Comments

Featured Broker Partners